Postmarketing Drug Safety Surveillance: An Overview of Regulatory Issues

By Wu J.H.  

Pharmaceutical Development and Regulation, Vol. 1, Iss. 4, 2003-01 ,pp. : 231-244

Adis International

Access to resources Recommend Favorite

Venous Thromboembolism in Myelodysplastic Syndrome Patients Receiving Lenalidomide: Results from Postmarketing Surveillance and Data Mining Techniques

By Yang Xionghu  

Clinical Drug Investigation, Vol. 29, Iss. 3, 2009-02 ,pp. : 161-171

Adis International

Access to resources Recommend Favorite

Cardiovascular Events in Patients taking Varenicline: A Case Series from Intensive Postmarketing Surveillance in New Zealand

By Harrison-Woolrych Mira  

Drug Safety, Vol. 35, Iss. 1, 2012-01 ,pp. : 33-43

Adis International

Access to resources Recommend Favorite

The Real-life Safety and Efficacy of Vardenafil: an International Post-marketing Surveillance Study – Results from 29 358 German Patients

By van Ahlen H   Zumbé J   Stauch K   Landen H  

The Journal of International Medical Research, Vol. 33, Iss. 3, 2005-05 ,pp. : 337-348

Field House Publishing

Access to resources Recommend Favorite

The Real-Life Safety and Efficacy of Vardenafil: An International Post-Marketing Surveillance Study of 2824 Patients from the Middle East

By Kamel A.  

Clinical Drug Investigation, Vol. 27, Iss. 5, 2007-01 ,pp. : 339-346

Adis International

Access to resources Recommend Favorite